Aril Pharma Limited
About Aril Pharma Limited
Data last updated: 24 July 2025
Aril Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 November 2002, the company has been in operation for over 24 years.
Registered with ROC Mumbai under CIN U33110MH2002PLC137788.
Capital: an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15.45 Lakh. It is led by directors including Vijay Kumar Chopra and Satish Surana.
Last AGM: 30 September 2011. Financial statements filed for year ended 31 March 2011. Office: C – 302 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per MCA filings, the company has satisfied charges of ₹19 Cr on record.
The company is currently under liquidation - its assets are being sold to settle outstanding debts. It may lack the legal capacity to fulfil new agreements, and creditors are prioritised in the distribution of proceeds.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressC – 302 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Board of Directors of Aril Pharma Limited
Aril Pharma Limited is currently managed by 4 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Chopra | Additional Director | 12 Jan 2009 | 17 Years 6 Months | As last reported |
|
Satish Surana
Also directs:
Raja Antibiotics Limited, Angeas Health Care Limited
|
Additional Director | 24 Aug 2009 | 16 Years 11 Months | As last reported |
|
Vaibhav Purnandu Jain
Also directs:
Althea Unilife Llp, Althea Pharma Private Limited, Attalika Impex Private Limited and 3 more
|
Director | 04 Apr 2008 | 18 Years 3 Months | As last reported |
| Anupama Purnandu Jain | Director | 30 Sep 2006 | 19 Years 9 Months | As last reported |
Financials of Aril Pharma Limited FY 2011 filings available
Ten-year financial statements for Aril Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aril Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2004 | State Bank of India | ₹9 Cr | Satisfied |
| 23 Jan 2004 | State Bank of India | ₹6 Cr | Satisfied |
| 23 Jan 2004 | State Bank of India | ₹4 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Aril Pharma Limited
View historical data on people associated with Aril Pharma Limited, including employment history and EPFO contributions.
Employee and EPFO history for Aril Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aril Pharma Limited
GST registrations and filing compliance for Aril Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aril Pharma Limited
Credit ratings, litigation, and regulatory alerts for Aril Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aril Pharma Limited
MSME payment history for Aril Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aril Pharma Limited
Corporate group structure for Aril Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aril Pharma Limited
MCA filings and documents for Aril Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aril Pharma Limited
Frequently Asked Questions about Aril Pharma Limited
Aril Pharma Limited is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Aril Pharma Limited is a company under liquidation, formerly operating as a public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 06 November 2002 and is registered under CIN U33110MH2002PLC137788. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
The current directors of Aril Pharma Limited are:
- Vijay Kumar Chopra - Additional Director
- Satish Surana - Additional Director
- Vaibhav Purnandu Jain - Director
- Anupama Purnandu Jain - Director
The CIN (Corporate Identification Number) of Aril Pharma Limited is U33110MH2002PLC137788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aril Pharma Limited has no open charges and satisfied charges of ₹19 Cr as per latest MCA filings.
The primary industry of Aril Pharma Limited is pharma. The company specifically operates in drug formulation and development.